BioCentury | Mar 24, 2008
Finance

Nomura's investments

...B, 2002 3i; MB Venture Capital Fund; Merlin Biosciences $52M series C, 2004 3i Group; Close Finsbury Eurotech; MB Venture Capital Fund...
BioCentury | May 9, 2006
Financial News

Onyvax raises L8 million

...Group and SR One. New investors Barrie Haigh and Alberville joined existing investors Merlin Biosciences; MB Venture Capital Fund...
BioCentury | May 8, 2006
Finance

Ebb & Flow

...was co-led by 3i and SR One with additional funds from Barrie Haigh; Merlin Biosciences; MB Venture Capital Fund...
BioCentury | May 23, 2005
Finance

U.S. investment in Europe

...Investment Partnership; 3i; Finsbury Life Sciences; Close Finsbury Eurotech; Nomura Phase4 Ventures; Merlin Bio sciences; MB Venture Capital Fund...
BioCentury | May 24, 2004
Finance

Top European B rounds

...Therascope AG Arakis $25.1 4/29/02 Drug delivery; pharmacogenetics; chemistry U.K. Nomura International; 3i; Merlin Biosciences; MB Venture Capital Fund...
BioCentury | Nov 15, 2000
Financial News

Onyvax raises EUR17.5 million

...Onyvax (London, U.K.) raised EUR17.5 million ($15 million) in a private financing through Merlin Biosciences; MB Venture Capital Fund...
Items per page:
1 - 6 of 6
BioCentury | Mar 24, 2008
Finance

Nomura's investments

...B, 2002 3i; MB Venture Capital Fund; Merlin Biosciences $52M series C, 2004 3i Group; Close Finsbury Eurotech; MB Venture Capital Fund...
BioCentury | May 9, 2006
Financial News

Onyvax raises L8 million

...Group and SR One. New investors Barrie Haigh and Alberville joined existing investors Merlin Biosciences; MB Venture Capital Fund...
BioCentury | May 8, 2006
Finance

Ebb & Flow

...was co-led by 3i and SR One with additional funds from Barrie Haigh; Merlin Biosciences; MB Venture Capital Fund...
BioCentury | May 23, 2005
Finance

U.S. investment in Europe

...Investment Partnership; 3i; Finsbury Life Sciences; Close Finsbury Eurotech; Nomura Phase4 Ventures; Merlin Bio sciences; MB Venture Capital Fund...
BioCentury | May 24, 2004
Finance

Top European B rounds

...Therascope AG Arakis $25.1 4/29/02 Drug delivery; pharmacogenetics; chemistry U.K. Nomura International; 3i; Merlin Biosciences; MB Venture Capital Fund...
BioCentury | Nov 15, 2000
Financial News

Onyvax raises EUR17.5 million

...Onyvax (London, U.K.) raised EUR17.5 million ($15 million) in a private financing through Merlin Biosciences; MB Venture Capital Fund...
Items per page:
1 - 6 of 6